Your search for apixaban returned 1 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Mital Patel, PharmD remove
Post remove
Drugs in the Pipeline remove

Your search for apixaban returned 1 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Eliquis Reversal Agent Demonstrates Efficacy in Phase 3 Study

Portola Pharmaceuticals, Bristol-Myers Squibb Company, and Pfizer announced results from the Phase 3 ANNEXA-A (Andexanet Alfa a Novel Antidote to the Anticoagulant Effects of FXa Inhibitors - Apixaban) study with andexanet alfa as a reversal agent for Eliquis (apixaban).